Pennsylvania-based EUSA Pharma (USA) Inc. will pay the U.S. government $180,000 for alleged False Claims Act violations. The Department of Justice alleged that the pharmaceutical company encouraged doctors to file inflated claims to the Medicare program for imaging scans.
EUSA Pharma manufactures and sells the radiopharmaceutical ProstaScint. Allegedly, the company encouraged healthcare providers to file multiple claims after imaging scans performed using ProstaScint, despite the fact that EUSA Pharma had been told by the Society of Nuclear Medicine that only one claim should be filed with Medicare for the imaging scans.
A former EUSA Pharma employee filed a qui tam lawsuit under the False Claims Act. The False Claims Act lets an individual file a lawsuit on behalf of the federal government and to receive a portion of any recovery. In this case, the whistleblower will receive a total of $30,600 for her role in uncovering this fraud against the government.
Waters & Kraus is a national firm with highly skilled lawyers practicing qui tam litigation in four offices, including Dallas, Los Angeles, San Francisco, and Baltimore. Our attorneys have decades of experience successfully representing whistleblowers in a variety of fraud cases. Contact us or call one of our attorneys at 800.226.9880 to learn more about our practice and how we can assist.
